Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Sep;104(1):71–76. doi: 10.1111/j.1476-5381.1991.tb12387.x

Antagonism of relaxin by glibenclamide in the uterus of the rat in vivo.

S J Downing 1, M Hollingsworth 1
PMCID: PMC1908304  PMID: 1664766

Abstract

1. The effects of glibenclamide (a blocker of adenosine triphosphate [ATP]-dependent K(+)-channels) on the inhibition of uterine contractions by relaxin, salbutamol and cromakalim were compared in vivo. 2. Glibenclamide (20 mg kg-1) did not antagonize salbutamol. Glibenclamide produced a parallel rightward shift in the dose-response curve to cromakalim with a 5.5 fold decrease in uterine sensitivity (post-vehicle log ID50, -0.87 mg kg-1; post-glibenclamide log ID50, -0.07 mg kg-1). Glibenclamide produced a non-parallel rightward shift in the dose-response curve to relaxin (post-vehicle log ID50, 0.99 microgram kg-1; post-glibenclamide log ID50, 2.28 micrograms kg-1). 3. Glibenclamide reversed established inhibition of uterine contractions by cromakalim or relaxin but not that by salbutamol. 4. Insulin produced no antagonism of relaxin on isolated uterus of the rat, demonstrating that glibenclamide antagonism of relaxin in vivo is not by released insulin. Apamin did not antagonize relaxin in vivo, suggesting that small calcium-activated K(+)-channels are not involved in the action of relaxin. 5. Comparison of the lack of antagonism of salbutamol with the non-competitive-like antagonism of relaxin by glibenclamide suggests that relaxin does not relax uterine smooth muscle predominantly by increasing intracellular adenosine 3', 5'-cyclic monophosphate concentrations. Comparison of the non-competitive-like antagonism of relaxin and the competitive-like antagonism of cromakalim by glibenclamide suggests that the two relaxants may share, in part, a common mechanism of action and that additional mechanism(s) may also be involved in the inhibitory action of relaxin.

Full text

PDF
71

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anwer K., Hovington J. A., Sanborn B. M. Antagonism of contractants and relaxants at the level of intracellular calcium and phosphoinositide turnover in the rat uterus. Endocrinology. 1989 Jun;124(6):2995–3002. doi: 10.1210/endo-124-6-2995. [DOI] [PubMed] [Google Scholar]
  2. Bradshaw J. M., Downing S. J., Moffatt A., Hinton J. C., Porter D. G. Demonstration of some of the physiological properties of rat relaxin. J Reprod Fertil. 1981 Sep;63(1):145–153. doi: 10.1530/jrf.0.0630145. [DOI] [PubMed] [Google Scholar]
  3. Buckingham R. E., Hamilton T. C., Howlett D. R., Mootoo S., Wilson C. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol. 1989 May;97(1):57–64. doi: 10.1111/j.1476-5381.1989.tb11923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cavero I., Mondot S., Mestre M. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther. 1989 Mar;248(3):1261–1268. [PubMed] [Google Scholar]
  5. Cheah S. H., Sherwood O. D. Effects of relaxin on in vivo uterine contractions in conscious and unrestrained estrogen-treated and steroid-untreated ovariectomized rats. Endocrinology. 1981 Dec;109(6):2076–2083. doi: 10.1210/endo-109-6-2076. [DOI] [PubMed] [Google Scholar]
  6. Cheah S. H., Sherwood O. D. Target tissues for relaxin in the rat: tissue distribution of injected 125I-labeled relaxin and tissue changes in adenosine 3',5'-monophosphate levels after in vitro relaxin incubation. Endocrinology. 1980 Apr;106(4):1203–1209. doi: 10.1210/endo-106-4-1203. [DOI] [PubMed] [Google Scholar]
  7. Cook N. S., Hof R. P. Cardiovascular effects of apamin and BRL 34915 in rats and rabbits. Br J Pharmacol. 1988 Jan;93(1):121–131. doi: 10.1111/j.1476-5381.1988.tb11412.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Downing S. J., Miller M., Hollingsworth M. Tolerance to cromakalim in the rat uterus in vivo. Br J Pharmacol. 1989 Mar;96(3):732–738. doi: 10.1111/j.1476-5381.1989.tb11875.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Downing S. J., Sherwood O. D. The physiological role of relaxin in the pregnant rat. I. The influence of relaxin on parturition. Endocrinology. 1985 Mar;116(3):1200–1205. doi: 10.1210/endo-116-3-1200. [DOI] [PubMed] [Google Scholar]
  10. Downing S. J., Sherwood O. D. The physiological role of relaxin in the pregnant rat. II. The influence of relaxin on uterine contractile activity. Endocrinology. 1985 Mar;116(3):1206–1214. doi: 10.1210/endo-116-3-1206. [DOI] [PubMed] [Google Scholar]
  11. Edwards G., Weston A. H. Potassium channel openers and vascular smooth muscle relaxation. Pharmacol Ther. 1990;48(2):237–258. doi: 10.1016/0163-7258(90)90082-d. [DOI] [PubMed] [Google Scholar]
  12. Escande D., Thuringer D., Le Guern S., Courteix J., Laville M., Cavero I. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes. Pflugers Arch. 1989 Sep;414(6):669–675. doi: 10.1007/BF00582134. [DOI] [PubMed] [Google Scholar]
  13. Geisen K. Special pharmacology of the new sulfonylurea glimepiride. Arzneimittelforschung. 1988 Aug;38(8):1120–1130. [PubMed] [Google Scholar]
  14. Ginsburg F. W., Rosenberg C. R., Schwartz M., Colon J. M., Goldsmith L. T. The effect of relaxin on calcium fluxes in the rat uterus. Am J Obstet Gynecol. 1988 Dec;159(6):1395–1401. doi: 10.1016/0002-9378(88)90563-7. [DOI] [PubMed] [Google Scholar]
  15. Granger S. E., Hollingsworth M., Weston A. H. A comparison of several calcium antagonists on uterine, vascular and cardiac muscles from the rat. Br J Pharmacol. 1985 May;85(1):255–262. doi: 10.1111/j.1476-5381.1985.tb08854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Johansson S. R., Andersson R. G. Effects of beta-adrenergic agonists on rat uterine motility and cAMP level in vivo. Acta Pharmacol Toxicol (Copenh) 1980 Jul;47(1):5–10. doi: 10.1111/j.1600-0773.1980.tb01651.x. [DOI] [PubMed] [Google Scholar]
  17. Judson D. G., Pay S., Bhoola K. D. Modulation of cyclic AMP in isolated rat uterine tissue slices by porcine relaxin. J Endocrinol. 1980 Oct;87(1):153–159. doi: 10.1677/joe.0.0870153. [DOI] [PubMed] [Google Scholar]
  18. Nara B. S., Welk F. A., Rutherford J. E., Sherwood O. D., First N. L. Effect of relaxin on parturition and frequency of live births in pigs. J Reprod Fertil. 1982 Sep;66(1):359–365. doi: 10.1530/jrf.0.0660359. [DOI] [PubMed] [Google Scholar]
  19. Newgreen D. T., Bray K. M., McHarg A. D., Weston A. H., Duty S., Brown B. S., Kay P. B., Edwards G., Longmore J., Southerton J. S. The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol. 1990 Jul;100(3):605–613. doi: 10.1111/j.1476-5381.1990.tb15854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Nishikori K., Weisbrodt N. W., Sherwood O. D., Sanborn B. M. Effects of relaxin on rat uterine myosin light chain kinase activity and myosin light chain phosphorylation. J Biol Chem. 1983 Feb 25;258(4):2468–2474. [PubMed] [Google Scholar]
  21. Piper I., Minshall E., Downing S. J., Hollingsworth M., Sadraei H. Effects of several potassium channel openers and glibenclamide on the uterus of the rat. Br J Pharmacol. 1990 Dec;101(4):901–907. doi: 10.1111/j.1476-5381.1990.tb14178.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Porter D. G., Downing S. J., Bradshaw J. M. Relaxin inhibits spontaneous and prostaglandin-driven myometrial activity in anaesthetized rats. J Endocrinol. 1979 Nov;83(2):183–192. doi: 10.1677/joe.0.0830183. [DOI] [PubMed] [Google Scholar]
  23. Quast U., Cook N. S. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide. J Pharmacol Exp Ther. 1989 Jul;250(1):261–271. [PubMed] [Google Scholar]
  24. Rao M. R., Sanborn B. M. Relaxin increases calcium efflux from rat myometrial cells in culture. Endocrinology. 1986 Jul;119(1):435–437. doi: 10.1210/endo-119-1-435. [DOI] [PubMed] [Google Scholar]
  25. Sanborn B. M., Kuo H. S., Weisbrodt N. W., Sherwood O. D. The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity. Endocrinology. 1980 Apr;106(4):1210–1215. doi: 10.1210/endo-106-4-1210. [DOI] [PubMed] [Google Scholar]
  26. Sherwood C. D., O'Byrne E. M. Purification and characterization of porcine relaxin. Arch Biochem Biophys. 1974 Jan;160(1):185–196. doi: 10.1016/s0003-9861(74)80025-1. [DOI] [PubMed] [Google Scholar]
  27. St-Louis J. Relaxin inhibition of KCl-induced uterine contractions in vitro: an alternative bioassay. Can J Physiol Pharmacol. 1981 May;59(5):507–512. doi: 10.1139/y81-076. [DOI] [PubMed] [Google Scholar]
  28. Standen N. B., Quayle J. M., Davies N. W., Brayden J. E., Huang Y., Nelson M. T. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989 Jul 14;245(4914):177–180. doi: 10.1126/science.2501869. [DOI] [PubMed] [Google Scholar]
  29. Sturgess N. C., Kozlowski R. Z., Carrington C. A., Hales C. N., Ashford M. L. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Br J Pharmacol. 1988 Sep;95(1):83–94. doi: 10.1111/j.1476-5381.1988.tb16551.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Weir S. W., Weston A. H. Effect of apamin on responses to BRL 34915, nicorandil and other relaxants in the guinea-pig taenia caeci. Br J Pharmacol. 1986 May;88(1):113–120. doi: 10.1111/j.1476-5381.1986.tb09477.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES